Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2024-06-07 00:00:00 ET · period of report 2024-06-05 · accession 0001593968-24-000835 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-07 | 2024-06-05 | ALLO | MESSEMER DEBORAH M. | Dir | A - Grant | $0.00 | +123.0K | 185.4K | +197% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-05 | A | A | 122,950 | $0.00 | 185,406 | D | — | — |